Johnny Yu
Overview
Contents7 sections
Key facts
Academic and industry research
Yu worked in research at the Broad Institute and Biogen before pursuing biochemistry and biophysics at the University of California, San Francisco. He earned his PhD and held a National Science Foundation Graduate Research Fellowship. His work investigated how RNA-binding proteins relate to cancer metastasis. He also worked at Millennium, part of Takeda.[1][2][3][4]
Founding Vevo and opening cancer research data
He co-founded Vevo Therapeutics, later renamed Tahoe, with Nima AlidoustNima AlidoustNima Alidoust is the co-founder and CEO of Tahoe. His background spans computational and quantum chemistry and management roles at 1QBit and Rigetti Computing.Open the full entry, Hani GoodarziHani GoodarziHani Goodarzi is an Iranian-born computational biologist, a faculty member at the University of California, San Francisco, and a co-founder of Tahoe. His research concerns RNA in cancer cells and its relationship to metastasis.Open the full entry and Kevan Shokat. As chief scientific officer, he led the Tahoe-100M project, making data available to researchers comparing how cancer cells respond to different drugs. He also led a market assessment case study at a startup workshop at UCSF.[1][2][3]
February 25, 2025Interview with No Priors
On February 25, 2025, No PriorsNo PriorsNo Priors is an AI interview podcast and media brand founded and hosted by investors Sarah Guo and Elad Gil, with episodes beginning in February 2023. It covers research, startups, infrastructure and business applications through guest interviews, host discussions and retrospectives distributed on audio platforms and YouTube.Open the full entry released an interview with Johnny Yu. He appeared alongside Nima Alidoust, Hani Goodarzi, Dave BurkeDave BurkeDave Burke is an engineer who led Google’s Android engineering team and became the Arc Institute’s first chief technology officer in 2024, applying software and machine learning to biomedical research.Open the full entry and Patrick HsuPatrick HsuPatrick Hsu is a biologist, a co-founder of the nonprofit biomedical research organization Arc Institute and an assistant professor of pathology at Stanford University.Open the full entry to discuss open single-cell data and how researchers can judge the predictive value of virtual cell models.[5]
Asked how many people did the hands-on work for Tahoe, Yu recalled that four people at Vevo completed that part in about three days.[5]
Advice Shared on No Priors
He cautioned that even a large collection assembled from smaller datasets has limited value to other users if labels are poor and batches differ. (09:37)[5]
He urged US biotechnology companies to cultivate innovation deliberately and avoid taking the country’s standing as an innovation hub for granted. (48:22)[5]
Related Organizations, Websites and Public Accounts
Tahoe: Co-founder and chief scientific officer. Official website: https://www.tahoelabs.ai/ (opens in a new window).[1]
X account: https://x.com/IAmJohnnyYu (opens in a new window).[5]
Sources5 sources
- About | Tahoe (opens in a new window)tahoelabs.ai↑
- Innovation Ventures Startup Workshop (opens in a new window)qbi.ucsf.edu↑
- Speaker Biographies — Discovery on Target (opens in a new window)giievent.jp↑
- Executive Conversations with Nosis Bio and Vevo: Using Generative AI on AWS to Shift the Pharmaceutical R&D Paradigm (opens in a new window)aws.amazon.com↑
- No Priors Ep. 103 | With Vevo Therapeutics and the Arc Institute (opens in a new window)youtube.com↑